Silica-triggered granulomatous lung disease shares NLRP3 and Th17.1 pathways with sarcoidosis
A European Respiratory Review paper, as summarised by ERS publications, says a continuum framework and the SISLR designation merit consideration, alongside standardisation of Si-LPT.
“a continuum framework and the SISLR designation merit consideration”— ERS publications
ERS publications said in a post on X that a paper in European Respiratory Review reports that silica-triggered granulomatous lung disease shares NLRP3 and Th17.1 pathways with sarcoidosis.
According to the post, the paper concludes that a continuum framework and the SISLR designation merit consideration. It also refers to the standardisation of Si-LPT, which it presents alongside those proposals.
The post is a brief summary with links to the full article. It does not describe the study design, the evidence behind the stated overlap, or the authors. It also does not explain how the proposed continuum framework or the SISLR designation would work in practice. Readers who want those details will need to consult the paper itself.
ERS publications, the account behind the post, describes itself as covering titles including the European Respiratory Journal, European Respiratory Review, ERJ Open Research and Breathe.
Original source
“a continuum framework and the SISLR designation merit consideration”
— ERS publications View the post on X
